Allied Corp., a Medical Cannabis Company, signs Master Services Agreement with Carmel – University of Haifa, Israel for Pre-clinical Pharmaceutical Development of a PTSD Drug.

KELOWNA, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, is pleased to announce it has entered into a Master Services Agreement with the University of Haifa, Israel via their wholly owned commercialization subsidiary: Carmel – Haifa University Economic Corporation Ltd. (“Haifa”). This world-class academic research center gives Allied access to a proprietary pre-clinical animal model that is owned by Carmel. Specifically, Allied will engage with this proprietary animal model for the purposes of specialized pharmaceutical cannabinoid research and pharmaceutical product development. Through this agreement, Allied now has access to Haifa’s leading-edge facilities, proprietary animal model, pharmaceutical development, academic laboratory and associated scientists and investigators. This will enable Allied to conduct the pre-clinical phase of the development of a proprietary pharmaceutical product for which Allied has patent-pending status. This pharmaceutical product (“AC001”) targets the treatment of Post-Traumatic Stress Disorder and related mental health conditions. Following the completion of the pre-clinical research phase, Allied intends to bring AC001 through human clinical trials. Following this, Allied intends to then seek a global commercialization relationship through a licensing deal for product AC001 with a big…

Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : Allied Corp., a Medical Cannabis Company, signs Master Services Agreement with Carmel – University of Haifa, Israel for Pre-clinical Pharmaceutical Development of a PTSD Drug.
reposted by Cannabis News World